Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP734327.RAtBQOlUpsCGESa2MqZ5AX6q6hcAqd1RprItz8Ka2Bsgs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP734327.RAtBQOlUpsCGESa2MqZ5AX6q6hcAqd1RprItz8Ka2Bsgs130_assertion type Assertion NP734327.RAtBQOlUpsCGESa2MqZ5AX6q6hcAqd1RprItz8Ka2Bsgs130_head.
- NP734327.RAtBQOlUpsCGESa2MqZ5AX6q6hcAqd1RprItz8Ka2Bsgs130_assertion description "[In cytopathologic examination, genomic amplification of TERC was found in 30 of 659 (4.6%) normal or benign cellular changes; in 23 of 170 (13.5%) atypical squamous cells of undetermined significance (ASCUS); in 8 of 28 (28.6%) atypical squamous cells with high-grade squamous intraepithelial lesion possible (ASC-H); and in 26 of 103 (25.2%) low-grade (LSIL) and 64 of 73 (87.7%) high-grade (HSIL) squamous intraepithelial lesions; with pairwise significant difference (P< 0.05) in each, except ASC-H and LSIL (chi(2) = 0.127, P = 0.72).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP734327.RAtBQOlUpsCGESa2MqZ5AX6q6hcAqd1RprItz8Ka2Bsgs130_provenance.
- NP734327.RAtBQOlUpsCGESa2MqZ5AX6q6hcAqd1RprItz8Ka2Bsgs130_assertion evidence source_evidence_literature NP734327.RAtBQOlUpsCGESa2MqZ5AX6q6hcAqd1RprItz8Ka2Bsgs130_provenance.
- NP734327.RAtBQOlUpsCGESa2MqZ5AX6q6hcAqd1RprItz8Ka2Bsgs130_assertion SIO_000772 19389503 NP734327.RAtBQOlUpsCGESa2MqZ5AX6q6hcAqd1RprItz8Ka2Bsgs130_provenance.
- NP734327.RAtBQOlUpsCGESa2MqZ5AX6q6hcAqd1RprItz8Ka2Bsgs130_assertion wasDerivedFrom befree-2016 NP734327.RAtBQOlUpsCGESa2MqZ5AX6q6hcAqd1RprItz8Ka2Bsgs130_provenance.
- NP734327.RAtBQOlUpsCGESa2MqZ5AX6q6hcAqd1RprItz8Ka2Bsgs130_assertion wasGeneratedBy ECO_0000203 NP734327.RAtBQOlUpsCGESa2MqZ5AX6q6hcAqd1RprItz8Ka2Bsgs130_provenance.